Contact this trialFirst, we need to learn more about you.
Chemotherapy Agent
Xevinapant + Chemoradiotherapy for Head and Neck Cancer
Recruiting1 awardPhase 3
San Francisco, California
This trial is testing whether adding the drug Xevinapant to standard chemoradiotherapy treatment can improve outcomes for people with locally advanced squamous cell carcinoma of the head and neck.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.